艾塞那肽应用于2型糖尿病的52周临床观察
Effects of Exenatide on Glycemic Control Over 52 Weeks in Patients with Type 2 Diabetes
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|